DOCSLIB.ORG

1) (As of December 2018) and the Latest GWAS of AD (2

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
1) (As of December 2018) and the Latest GWAS of AD (2 SUPPLEMENTARY FIGURES downstream intergenic ncRNA_exonic upstream ●936 ●918 group downstream intergenic ncRNA_exonic upstream group exonic exonicintronicintronic ncRNA_intronic ncRNA_intronicUTR3 UTR3 3.8% 1.2%1.5%1.9% 3.8% 5.4%5.4% 750 0.3% 3.8%1.2%1.5%1.9% ●700 5.4% ●670 0.3% 500 45.8% 40.240.2% % 45.8% ●329 ●274 250 ●223 Number (GWAS SNPs/studies) Number (GWAS ●128 ●105 45.8% ●54 ●57 ●58 ●48 ●42 ●46 ●50 ●30 ●3740.2% ● ●17 ●25 ●4 ●6 ●12 0 ● 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 Year Supplementary Figure S1. GWAS of AD since 2007. The figure is based on data from the GWAS Catalog (1) (as of December 2018) and the latest GWAS of AD (2). The green area shows the total number of AD-associated SNPs, and the purple area shows the total number of GWAS of AD. The insert chart shows the proportions of different types of all 936 AD-associated SNPs. 1 100 200 RPS27A TGFB2 BIN1 C4BPB MSH2 PROC UGT1A1 RAB1A TTN DISC1 50 PDCL3 COL4A3 CD55 ERCC3 100 USP21 C4BPA ITSN2 PTPRF MPZ FMN2 INPP5D CEP85 FNBP1L CSF1 CD46 ADAMTS4 PRKRA SPRED2 0 CTNNA2 DGKD ADCY10 ZAP70 LIMS2 PDE1A PROX1 0 CHRNB2 CR1 HSPG2 SH3BGRL3 DAB1 CTBS FCER1G MAP3K2 AD risk score or log10(P value) IL6R CDC73 CD34 AD risk score or log10(P value) −50 B4GALT3 IL19 0 50 100 150 200 250 0 50 100 150 200 Chromosome 1 (Mb) Chromosome 2 (Mb) ATP2B2 LTF ARF4 MECOM PAK2 EPHB1 40 VHL PRSS42 ARL6IP5 150 COL25A1 TDGF1 RPSA CCR2 CCR1 IL1RAP IRAK2 20 PTPRG 100 FLNB TF CX3CR1 IL17RD SH3RF1 FGG FANCD2 LIMD1 CCR5 50 0 WDR1 PDGFRA EIF4E FGB AD risk score or log10(P value) AD risk score or log10(P value) 0 FGA HMGB2 −20 0 50 100 150 200 0 50 100 150 Chromosome 3 (Mb) Chromosome 4 (Mb) 75 BAG6 HSPA1B SYNGAP1 F2R NOTCH4 SNX9 75 HSPA1A PSMB8 RAD50 MAML1 SQSTM1 SGK1 50 TFEB MEF2C C4B AGER RPS6KA2 SERINC5 CSF2 HBEGF DDX41 50 C4A CD2AP PJA2 SLC35A1 FGF10 IQGAP2 GLRA1 CANX 25 GNMT CDKAL1 IL3 TIAM2 25 FNIP1 PDLIM7 TMEM30A APOM TREM2 CUL7 ATF6B C2 DHFR 0 MAP3K1 HINT1 B4GALT7 TMED9 HLA−DRA 0 CFB CSNK2B AD risk score or log10(P value) CAMK4 AD risk score or log10(P value) SPARC MSX2 PSMB9 −25 0 50 100 150 0 50 100 150 Chromosome 5 (Mb) Chromosome 6 (Mb) 40 PDGFA LMTK2 RELN WEE2 PTK2B EXOC4 CNTNAP2 ELMO1 CLU AZGP1 GPC2 60 SCIN TNFRSF10B TFR2 EPHA1 20 SLC25A13 DLC1 CYCS NME8 ZYX ESCO2 GGH SGK3 PCOLCE KEL 30 HDAC9 LAMTOR4 PBK ADCY8 ADRA1A PTPRZ1 TRIP6 TTPA TP53INP1 0 0 AD risk score or log10(P value) AD risk score or log10(P value) −20 0 50 100 150 0 50 100 Chromosome 7 (Mb) Chromosome 8 (Mb) 50 ABCA1 KIAA1432 PCSK5 PAX2 40 GRIN1 60 TSPAN15 30 CASP7 NSMF 40 WAC 20 NFIB MUSK 20 NRG3 10 VPS13A ATP5C1 KIF5B 0 0 AD risk score or log10(P value) AD risk score or log10(P value) −10 0 50 100 0 50 100 Chromosome 9 (Mb) Chromosome 10 (Mb) 40 ERBB3 ULK1 FOLH1 SORL1 PRICKLE1 100 PSMC3 PICALM CASP4 KRAS BRSK2 RRAS2 30 TESC NR1H3 B3GAT3 ATM CNTN1 DLG2 A2M PTPRJ AICDA EIF2B1 DEAF1 CHID1 50 PACSIN3 SHANK2 CHEK1 20 HMGA2 DYNC2H1 PDE3B 10 SYTL2 CASP12 0 UBXN1 IRF7 AP2A2 LRP4 RAPSN 0 TENM4 MMP3 AD risk score or log10(P value) GNG3 AD risk score or log10(P value) TOLLIP NDUFS3 GANAB −50 −10 0 50 100 0 50 100 Chromosome 11 (Mb) Chromosome 12 (Mb) 2 30 PCID2 SNX6 FARP1 40 ERO1L SLITRK1 20 ADPRHL1 PSMC6 RNF6 ATXN3 20 10 STYX GPR68 0 0 AD risk score or log10(P value) AD risk score or log10(P value) 25 50 75 100 20 40 60 80 100 Chromosome 13 (Mb) Chromosome 14 (Mb) PYCARD CDH13 USP8 PDPK1 STX4 RNF40 100 40 PLCG2 JPH3 APH1B TRIM72 RHBDF1 STX1B SPPL2A ADAM10 CDH1 MAP2K5 PRSS8 PIAS1 20 USP10 50 DUOX1 CLN6 EEF2K AKAP13 KAT8 CDH3 HERC2 SNX1 PCSK6 SORD ALDH1A2 0 NMB AD risk score or log10(P value) LINGO1 AD risk score or log10(P value) 0 SKOR1 RORA RPS27L 40 60 80 100 0 25 50 75 Chromosome 15 (Mb) Chromosome 16 (Mb) 80 USP6 SPPL2C PHB ACE TIMP2 60 CDK5RAP3 PSMC5 PMAIP1 MAPT TMC8 ALOX12 GRB2 60 TRIM37 40 CRHR1 GH1 MALT1 NSF SUMO2 40 ENO3 OSBPL7 BCAS3 DUSP3 20 STRADA PLD2 20 NMT1 RNF43 RPTOR 0 AD risk score or log10(P value) AD risk score or log10(P value) 0 20 40 60 80 0 20 40 60 Chromosome 17 (Mb) Chromosome 18 (Mb) APOE BAX APOC1 APOC2 100 FGF22 ABCA7 MARK4 CALM3 CST3 QPCTL STK11 BCL3 100 0 CBLC CYTH2 TMEM259 BSG RELB CSNK2A1 PTPN1 AURKA −100 SPHK2 ERCC2 50 ASIP PLCG1 RBCK1 −200 TBC1D20 ADNP AHCY AD risk score or log10(P value) AD risk score or log10(P value) EDEM2 0 ANGPT4 −300 0 20 40 0 20 40 Chromosome 19 (Mb) Chromosome 20 (Mb) SYNJ1 TMPRSS6 CYP2D6 MAPK12 40 30 NCF4 ABCG1 ARSA PDE9A SREBF2 30 CSF2RB MLC1 20 COL18A1 IL2RB 20 CCT8 SIK1 10 10 0 0 AD risk score or log10(P value) AD risk score or log10(P value) −10 25 30 35 40 45 20 30 40 50 Chromosome 21 (Mb) Chromosome 22 (Mb) Supplementary Figure S2. GWAS AD SNPs, AD risk regions, AD risk gene candidates, and predicted AD risk genes in each human autosome. Green dots below the black dashed line represent GWAS AD SNPs and their log10P values. Above the black dashed line, gray dots represent AD risk gene candidates, and red ones predicted AD risk genes (labelled with gene symbols). The red dashed line marks the threshold for AD risk gene prediction based on the stringent training. AD risk genes below this threshold were predicted with the lenient training gene set. Vertical lines represent AD risk regions: red for risk regions with AD risk genes, blue for risk regions with only AD risk gene candidates, gray for risk regions without any AD risk gene candidates. 3 Color Key Color Key −3 −2 −1 0 1 2 3 Z Score Islet cells Bladder Placenta CD105+ Endothelial Esophagus Small intestine Colon Uterus HINT1 NDUFS3 ATP5C1 −3 −2 −1 0 1 2 3 CYCS HERC2 TRIM37 PSMC5 Z Score DDX41 SUMO2 NMT1 EIF2B1 ES cells Stem cells B cells T cells Myeloid cells CNS Thyroid Pancreas Muscle Heart Kidney Liver Adipose Airway Skin Salivary gland Stomach Appendix Ovary Breast Testis PCID2 Conjunctiva PRKRA RAD50 MSH2 HMGB2 CCT8 RNF6 PSMC6 EIF4E TMEM30A USP8 SLC35A1 ARL6IP5 MAML1 ADNP ITSN2 PIAS1 SORL1 KRAS HINT1 WAC NDUFS3 PBK ATP5C1 AURKA CYCS GGH HERC2 DHFR TRIM37 CHEK1 PSMC5 CSNK2A1 DDX41 PSMC3 SUMO2 GANAB NMT1 BSG EIF2B1 AHCY PCID2 PHB PRKRA RPS27L RAD50 TMED9 MSH2 RRAS2 HMGB2 FLNB CCT8 PTK2B RNF6 B3GAT3 PSMC6 ULK1 EIF4E SPHK2 TMEM30A AP2A2 USP8 USP21 SLC35A1 PLCG1 ARL6IP5 LIMS2 MAML1 PDE9A ADNP CDK5RAP3ITSN2 ERCC3 PIAS1 UBXN1 SORL1 STRADA KRAS ABCA7 WAC DGKD PBK PDPK1 AURKA AKAP13 GGH KIF5B DHFR F2R CHEK1 HMGA2 CSNK2A1 CYTH2 PSMC3 CD34 GANAB RNF40 BSG CLN6 AHCY CUL7 PHB B4GALT7 RPS27L ERCC2 TMED9 PMAIP1 RRAS2 IQGAP2 FLNB CD55 PTK2B BCL3 B3GAT3 CSF2RB ULK1 RELB SPHK2 B4GALT3 AP2A2 SH3BGRL3USP21 PYCARD PLCG1 EDEM2 LIMS2 INPP5D PDE9A NCF4 CDK5RAP3 PTPN1 ERCC3 MALT1 UBXN1 STX4 STRADA SNX6 ABCA7 PSMB8 DGKD PSMB9 PDPK1 RBCK1 AKAP13 PAK2 KIF5B IRF7 F2R CASP4 HMGA2 BAX CYTH2 WDR1 CD34 ADAM10 RNF40 GRB2 CLN6 USP10 CUL7 IL2RB B4GALT7 ZAP70 ERCC2 ATM PMAIP1 RORA IQGAP2 SPRED2 CD55 SLC25A13 BCL3 ABCA1 CSF2RB CD2AP RELB CASP7 B4GALT3 ABCG1 SH3BGRL3 CANX PYCARD ARF4 EDEM2 RAB1A INPP5D SGK1 NCF4 HBEGF PTPN1 TNFRSF10BMALT1 CD46 STX4 CDC73 SNX6 CTBS PSMB8 SNX1 PSMB9 HLA−DRA RBCK1 PLCG2 PAK2 TFEB IRF7 TIMP2 CASP4 PICALM BAX FCER1G WDR1 CCR1 ADAM10 NR1H3 GRB2 C2 USP10 ERO1L IL2RB TREM2 ZAP70 CSF1 ATM MEF2C RORA HDAC9 SPRED2 MARK4 SLC25A13 BCAS3 ABCA1 VPS13A CD2AP USP6 CASP7 PDE1A ABCG1 PJA2 CANX NSF ARF4 SYNJ1 RAB1A ELMO1 SGK1 MLC1 HBEGF BIN1 TNFRSF10B CX3CR1 CD46 PTPRZ1 CDC73 LRP4 CTBS SHANK2 SNX1 DEAF1 HLA−DRA GNG3 PLCG2 ATP2B2 TFEB MAPT TIMP2 CNTNAP2 PICALM CTNNA2 FCER1G GRIN1 CCR1 SREBF2 NR1H3 RELN C2 EPHB1 ERO1L DLG2 TREM2 BRSK2 CSF1 CNTN1 MEF2C JPH3 HDAC9 NOTCH4 MARK4 CHRNB2 BCAS3 PLD2 VPS13A TOLLIP USP6 NMB PDE1A CLU PJA2 A2M NSF APOE SYNJ1 APOC1 ELMO1 TF MLC1 PCSK6 BIN1 TSPAN15 CX3CR1 ERBB3 PTPRZ1 FOLH1 LRP4 PDGFA SHANK2 SQSTM1 DEAF1 DUSP3 GNG3 ZYX ATP2B2 PDLIM7 MAPT ALDH1A2 CNTNAP2 ACE CTNNA2 APH1B GRIN1 FNBP1L SREBF2 SORD RELN CDH1 EPHB1 PRSS8 DLG2 DUOX1 BRSK2 TRIP6 CNTN1 COL18A1 JPH3 RHBDF1 NOTCH4 HSPG2 CHRNB2 PCOLCE PLD2 PDGFRA TOLLIP SPARC NMB NFIB CLU RPS6KA2 A2M PTPRF APOE FARP1 APOC1 CDH13 TF DLC1 PCSK6 PTPRG TSPAN15 DYNC2H1 ERBB3 FOLH1 CFB PDGFA OSBPL7 SQSTM1 CRHR1 DUSP3 VHL ZYX GLRA1 PDLIM7 LMTK2 ALDH1A2 ADRA1A ACE MUSK APH1B PTPRJ FNBP1L LIMD1 SORD ASIP CDH1 ADCY10 PRSS8 TTPA DUOX1 MSX2 TRIP6 TGFB2 COL18A1 MAP3K1 RHBDF1 FGF22 HSPG2 MAPK12 PCOLCE MPZ PDGFRA DAB1 SPARC QPCTL NFIB COL4A3 RPS6KA2 CYP2D6 PTPRF SCIN FARP1 PAX2 CDH13 ANGPT4 DLC1 RAPSN PTPRG GPR68 DYNC2H1 MAP2K5 CFB CAMK4 OSBPL7 ATF6B CRHR1 TIAM2 VHL PDE3B GLRA1 PCSK5 LMTK2 DISC1 ADRA1A IL6R MUSK MAP3K2 PTPRJ CDKAL1 LIMD1 ATXN3 ASIP IL1RAP ADCY10 CR1 TTPA SYTL2 MSX2 CSF2 TGFB2 IL3 MAP3K1 PACSIN3 FGF22 TTN MAPK12 ENO3 MPZ TESC DAB1 TFR2 QPCTL APOM COL4A3 STK11 CYP2D6 KEL SCIN LTF PAX2 AZGP1 ANGPT4 GNMT RAPSN RNF43 GPR68 EPHA1 MAP2K5 CDH3 CAMK4 ALOX12 ATF6B AICDA TIAM2 MMP3 PDE3B IL19 PCSK5 CBLC DISC1 TMPRSS6 IL6R ARSA MAP3K2 PROX1 CDKAL1 AGER ATXN3 C4BPA IL1RAP PROC CR1 C4BPB SYTL2 FGG CSF2 FGA IL3 FGB PACSIN3 TTN ES cells CD34+ CD38 blood HSC fetal CD34+ CD38 HSC cord blood CD34+ CD38 HSC cord blood CD34+ CD38 HSC bone marrow CD34+ CD38+ blood HSC fetal CD34+ CD38+ HSC cord blood CD34+ CD38+ CD33 HSC cord blood HSC periph CD34+ CD38+ blood CD34+ CD38+ HSC bone marrow CD34+ CD38+ CD33 HSC bone marrow CD34+ Bone marrow CD34+ B cells cord blood B cells Pro B cells PreI B cells PreII B cells immature B cells CD19+ Tonsils node Lymph Thymus CD34+ T cells cord blood CD34+ Thymic CD34+CD38+ CD1A Thymic CD34+CD38+ CD1A+ Thymic CD4+CD8 Thymic CD4+CD8+CD3 Thymic CD4+CD8+CD3+ Thymic SP CD4+ T cells Thymic CD4+ T cells naive Peripheral Th1 Th2 SP CD8+ T cells Thymic CD8+ T cells Peripheral CD4+ T cells Tonsils T cells BAFF+ T cells CD57+ memoryT cells central memory T cells effector T cells gammadelta Treg NK CD56+ DC Immature DC LPS 6h DC
Load more

Recommended publications
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Aneuploidy: Using Genetic Instability to Preserve a Haploid Genome?
    Health Science Campus FINAL APPROVAL OF DISSERTATION Doctor of Philosophy in Biomedical Science (Cancer Biology) Aneuploidy: Using genetic instability to preserve a haploid genome? Submitted by: Ramona Ramdath In partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biomedical Science Examination Committee Signature/Date Major Advisor: David Allison, M.D., Ph.D. Academic James Trempe, Ph.D. Advisory Committee: David Giovanucci, Ph.D. Randall Ruch, Ph.D. Ronald Mellgren, Ph.D. Senior Associate Dean College of Graduate Studies Michael S. Bisesi, Ph.D. Date of Defense: April 10, 2009 Aneuploidy: Using genetic instability to preserve a haploid genome? Ramona Ramdath University of Toledo, Health Science Campus 2009 Dedication I dedicate this dissertation to my grandfather who died of lung cancer two years ago, but who always instilled in us the value and importance of education. And to my mom and sister, both of whom have been pillars of support and stimulating conversations. To my sister, Rehanna, especially- I hope this inspires you to achieve all that you want to in life, academically and otherwise. ii Acknowledgements As we go through these academic journeys, there are so many along the way that make an impact not only on our work, but on our lives as well, and I would like to say a heartfelt thank you to all of those people: My Committee members- Dr. James Trempe, Dr. David Giovanucchi, Dr. Ronald Mellgren and Dr. Randall Ruch for their guidance, suggestions, support and confidence in me. My major advisor- Dr. David Allison, for his constructive criticism and positive reinforcement.
    [Show full text]
  • RNA Sequencing of Whole Blood in Discordant Twin and Case-Controlled Cohorts
    Biomarker Discovery in Attention Decit Hyperactivity Disorder: RNA sequencing of Whole Blood in Discordant Twin and Case-Controlled Cohorts Timothy A. McCaffrey ( [email protected] ) George Washington University Medical Center https://orcid.org/0000-0002-4648-7833 Georges St. Laurent III The St. Laurent Institute Dmitry Shtokalo Institut sistem informatiki imeni A P Ersova SO RAN Denis Antonets A P Ershov Institute of Informatics Systems SB RAS: Institut sistem informatiki imeni A P Ersova SO RAN Yuri Vyatkin Janssen Research and Development LLC Daniel Jones Amgen Inc Eleanor Battison Oregon Health & Science University - West Campus Joel T. Nigg Oregon Health & Science University Research article Keywords: attention-decit/hyperactivity disorder (ADHD), RNA sequencing, transcriptome, GIT1, galactose, twins Posted Date: October 22nd, 2020 DOI: https://doi.org/10.21203/rs.3.rs-20756/v3 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/34 Version of Record: A version of this preprint was published on October 28th, 2020. See the published version at https://doi.org/10.1186/s12920-020-00808-8. Page 2/34 Abstract Background: A variety of DNA-based methods have been applied to identify genetic markers of attention decit hyperactivity disorder (ADHD), but the connection to RNA-based gene expression has not been fully exploited. Methods: Using well dened cohorts of discordant, monozygotic twins from the Michigan State University Twin Registry, and case-controlled ADHD cases in adolescents, the present studies utilized advanced single molecule RNA sequencing to identify expressed changes in whole blood RNA in ADHD. Multiple analytical strategies were employed to narrow differentially expressed RNA targets to a small set of potential biomarkers of ADHD.
    [Show full text]
  • Genetic Research
    Genetic Research Who Is At Risk for Alcoholism? Tatiana Foroud, Ph.D.; Howard J. Edenberg, Ph.D.; and John C. Crabbe, Ph.D. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) was founded 40 years ago to help elucidate the biological underpinnings of alcohol dependence, including the potential contribution of genetic factors. Twin, adoption, and family studies conclusively demonstrated that genetic factors account for 50 to 60 percent of the variance in risk for developing alcoholism. Case–control studies and linkage analyses have helped identify DNA variants that contribute to increased risk, and the NIAAA­sponsored Collaborative Studies on Genetics of Alcoholism (COGA) has the expressed goal of identifying contributing genes using state­of­the­art genetic technologies. These efforts have ascertained several genes that may contribute to an increased risk of alcoholism, including certain variants encoding alcohol­metabolizing enzymes and neurotransmitter receptors. Genome­wide association studies allowing the analysis of millions of genetic markers located throughout the genome will enable discovery of further candidate genes. In addition to these human studies, genetic animal models of alcohol’s effects and alcohol use have greatly advanced our understanding of the genetic basis of alcoholism, resulting in the identification of quantitative trait loci and allowing for targeted manipulation of candidate genes. Novel research approaches—for example, into epigenetic mechanisms of gene regulation—also are under way and undoubtedly
    [Show full text]
  • LSCC SNP Variant Regulates SOX2 Modulation of VDAC3
    www.oncotarget.com Oncotarget, 2018, Vol. 9, (No. 32), pp: 22340-22352 Research Paper LSCC SNP variant regulates SOX2 modulation of VDAC3 Jacqueline Chyr1,3, Dongmin Guo2 and Xiaobo Zhou2,3 1Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA 2Center for Bioinformatics and Systems Biology, Department of Radiology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA 3School of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, TX 77030, USA Correspondence to: Xiaobo Zhou, email: [email protected] Keywords: lung cancer; SOX2; eQTL; SNP; topologically associating domain Received: June 21, 2017 Accepted: February 28, 2018 Published: April 27, 2018 Copyright: Chyr et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Lung squamous cell carcinoma (LSCC) is a genomically complex malignancy with no effective treatments. Recent studies have found a large number of DNA alterations such as SOX2 amplification in LSCC patients. As a stem cell transcription factor, SOX2 is important for the maintenance of pluripotent cells and may play a role in cancer. To study the downstream mechanisms of SOX2, we employed expression quantitative trait loci (eQTLs) technology to investigate how the presence of SOX2 affects the expression of target genes. We discovered unique eQTLs, such as rs798827-VDAC3 (FDR p-value = 0.0034), that are only found in SOX2-active patients but not in SOX2- inactive patients.
    [Show full text]
  • Genetic Analysis of Ethanol Sensitivity and Tolerance in Drosophila
    Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2013 Genetic Analysis of Ethanol Sensitivity and Tolerance in Drosophila Robin Chan Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/etd Part of the Medical Genetics Commons © The Author Downloaded from https://scholarscompass.vcu.edu/etd/3154 This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. Title Page GENETIC ANALYSIS OF ETHANOL SENSITIVITY AND TOLERANCE IN DROSOPHILA A Thesis Submitted in Partial Fulfillment of the Requirements for the Degree of Master of Science at Virginia Commonwealth University. by Robin F. Chan B.S., James Madison University, 2009 Advisor: Mike S. Grotewiel, Ph.D. Dept. of Human and Molecular Genetics Virginia Commonwealth University Richmond, Virginia July 2013 Abstract Genetic Analysis of Ethanol Sensitivity and Tolerance in Drosophila By Robin F. Chan, B.S. A Thesis Submitted in Partial Fulfillment of the Requirements for the Degree of Master of Science at Virginia Commonwealth University. Virginia Commonwealth University, 2013 Advisor: Mike S. Grotewiel, Ph.D. - Dept. Human and Molecular Genetics The genetic pathways influencing alcohol abuse and dependence are poorly characterized. Many critical discoveries about the interactions between ethanol-related behaviors and genetics have been made in the fruit fly Drosophila melanogaster. Coupling the statistical power of model organism studies to human association studies bolsters the analytical efficacy of these genomic approaches.
    [Show full text]
  • Content Based Search in Gene Expression Databases and a Meta-Analysis of Host Responses to Infection
    Content Based Search in Gene Expression Databases and a Meta-analysis of Host Responses to Infection A Thesis Submitted to the Faculty of Drexel University by Francis X. Bell in partial fulfillment of the requirements for the degree of Doctor of Philosophy November 2015 c Copyright 2015 Francis X. Bell. All Rights Reserved. ii Acknowledgments I would like to acknowledge and thank my advisor, Dr. Ahmet Sacan. Without his advice, support, and patience I would not have been able to accomplish all that I have. I would also like to thank my committee members and the Biomed Faculty that have guided me. I would like to give a special thanks for the members of the bioinformatics lab, in particular the members of the Sacan lab: Rehman Qureshi, Daisy Heng Yang, April Chunyu Zhao, and Yiqian Zhou. Thank you for creating a pleasant and friendly environment in the lab. I give the members of my family my sincerest gratitude for all that they have done for me. I cannot begin to repay my parents for their sacrifices. I am eternally grateful for everything they have done. The support of my sisters and their encouragement gave me the strength to persevere to the end. iii Table of Contents LIST OF TABLES.......................................................................... vii LIST OF FIGURES ........................................................................ xiv ABSTRACT ................................................................................ xvii 1. A BRIEF INTRODUCTION TO GENE EXPRESSION............................. 1 1.1 Central Dogma of Molecular Biology........................................... 1 1.1.1 Basic Transfers .......................................................... 1 1.1.2 Uncommon Transfers ................................................... 3 1.2 Gene Expression ................................................................. 4 1.2.1 Estimating Gene Expression ............................................ 4 1.2.2 DNA Microarrays ......................................................
    [Show full text]
  • Whole Exome Sequencing of ENU-Induced Thrombosis Modifier
    bioRxiv preprint doi: https://doi.org/10.1101/174086; this version posted March 24, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 2 Whole exome sequencing of ENU-induced thrombosis modifier 3 mutations in the mouse 4 5 Short title: 6 Identifying thrombosis modifier genes 7 8 Kärt Tomberg1,#a, Randal J. Westrick2, Emilee N. Kotnik3,#b, David R Siemieniak3,4, 9 Guojing Zhu3, Thomas L. Saunders5,6, Audrey C. Cleuren3, and David Ginsburg1,3,4,5,7,* 10 11 1Department of Human Genetics, University of Michigan, Ann Arbor, Michigan, United 12 States of America 13 2Department of Biological Sciences and Center for Data Science and Big Data Analysis, 14 Oakland University, Rochester, Michigan, United States of America 15 3Life Sciences Institute, University of Michigan, Ann Arbor, Michigan, United States of 16 America 17 4Howard Hughes Medical Institute, University of Michigan, Ann Arbor, Michigan, United 18 States of America 19 5Departments of Internal Medicine, Division of Molecular Medicine and Genetics, 20 University of Michigan, Ann Arbor, Michigan, United States of America 21 6Transgenic Animal Model Core Laboratory, University of Michigan, Ann Arbor, 22 Michigan, United States of America bioRxiv preprint doi: https://doi.org/10.1101/174086; this version posted March 24, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • Identification of Acquired Copy Number Alterations and Uniparental
    Leukemia (2010) 24, 438–449 & 2010 Macmillan Publishers Limited All rights reserved 0887-6924/10 $32.00 www.nature.com/leu ORIGINAL ARTICLE Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis L Bullinger1,4, J Kro¨nke1,4, C Scho¨n1,4, I Radtke2, K Urlbauer1, U Botzenhardt1, V Gaidzik1, A Cario´ 1, C Senger1, RF Schlenk1, JR Downing2, K Holzmann3,KDo¨hner1 and H Do¨hner1 1Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany; 2Department of Pathology, St Jude Children’s Research Hospital, Memphis, TN, USA and 3Microarray Core Facility, University of Ulm, Ulm, Germany Recent advances in genome-wide single-nucleotide polymorph- tyrosine kinase 3 (FLT3) gene the CCAAT/enhancer binding ism (SNP) analyses have revealed previously unrecognized protein-a (CEBPA) gene, the myeloid-lymphoid or mixed-line- microdeletions and uniparental disomy (UPD) in a broad age leukemia (MLL) gene, the neuroblastoma RAS viral spectrum of human cancers. As acute myeloid leukemia (AML) represents a genetically heterogeneous disease, this oncogene homolog (NRAS) gene, the Wilms’ tumor 1 (WT1) technology might prove helpful, especially for cytogenetically gene, and the runt-related transcription factor 1 (RUNX1) 4,5 normal AML (CN-AML) cases. Thus, we performed high- gene. These aberrations underscore the genetic complexity resolution SNP analyses in 157 adult cases of CN-AML. Regions of CN-AML and many additional genetic lesions are expected to of acquired UPDs were identified in 12% of cases and in the be present in this subset of AML.
    [Show full text]
  • A Network Inference Approach to Understanding Musculoskeletal
    A NETWORK INFERENCE APPROACH TO UNDERSTANDING MUSCULOSKELETAL DISORDERS by NIL TURAN A thesis submitted to The University of Birmingham for the degree of Doctor of Philosophy College of Life and Environmental Sciences School of Biosciences The University of Birmingham June 2013 University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is copyright of the author and/or third parties. The intellectual property rights of the author or third parties in respect of this work are as defined by The Copyright Designs and Patents Act 1988 or as modified by any successor legislation. Any use made of information contained in this thesis/dissertation must be in accordance with that legislation and must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the permission of the copyright holder. ABSTRACT Musculoskeletal disorders are among the most important health problem affecting the quality of life and contributing to a high burden on healthcare systems worldwide. Understanding the molecular mechanisms underlying these disorders is crucial for the development of efficient treatments. In this thesis, musculoskeletal disorders including muscle wasting, bone loss and cartilage deformation have been studied using systems biology approaches. Muscle wasting occurring as a systemic effect in COPD patients has been investigated with an integrative network inference approach. This work has lead to a model describing the relationship between muscle molecular and physiological response to training and systemic inflammatory mediators. This model has shown for the first time that oxygen dependent changes in the expression of epigenetic modifiers and not chronic inflammation may be causally linked to muscle dysfunction.
    [Show full text]
  • Analyzing the Mirna-Gene Networks to Mine the Important Mirnas Under Skin of Human and Mouse
    Hindawi Publishing Corporation BioMed Research International Volume 2016, Article ID 5469371, 9 pages http://dx.doi.org/10.1155/2016/5469371 Research Article Analyzing the miRNA-Gene Networks to Mine the Important miRNAs under Skin of Human and Mouse Jianghong Wu,1,2,3,4,5 Husile Gong,1,2 Yongsheng Bai,5,6 and Wenguang Zhang1 1 College of Animal Science, Inner Mongolia Agricultural University, Hohhot 010018, China 2Inner Mongolia Academy of Agricultural & Animal Husbandry Sciences, Hohhot 010031, China 3Inner Mongolia Prataculture Research Center, Chinese Academy of Science, Hohhot 010031, China 4State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China 5Department of Biology, Indiana State University, Terre Haute, IN 47809, USA 6The Center for Genomic Advocacy, Indiana State University, Terre Haute, IN 47809, USA Correspondence should be addressed to Yongsheng Bai; [email protected] and Wenguang Zhang; [email protected] Received 11 April 2016; Revised 15 July 2016; Accepted 27 July 2016 Academic Editor: Nicola Cirillo Copyright © 2016 Jianghong Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Genetic networks provide new mechanistic insights into the diversity of species morphology. In this study, we have integrated the MGI, GEO, and miRNA database to analyze the genetic regulatory networks under morphology difference of integument of humans and mice. We found that the gene expression network in the skin is highly divergent between human and mouse.
    [Show full text]
  • Signatures of Adaptive Evolution in Platyrrhine Primate Genomes 5 6 Hazel Byrne*, Timothy H
    1 2 Supplementary Materials for 3 4 Signatures of adaptive evolution in platyrrhine primate genomes 5 6 Hazel Byrne*, Timothy H. Webster, Sarah F. Brosnan, Patrícia Izar, Jessica W. Lynch 7 *Corresponding author. Email [email protected] 8 9 10 This PDF file includes: 11 Section 1: Extended methods & results: Robust capuchin reference genome 12 Section 2: Extended methods & results: Signatures of selection in platyrrhine genomes 13 Section 3: Extended results: Robust capuchins (Sapajus; H1) positive selection results 14 Section 4: Extended results: Gracile capuchins (Cebus; H2) positive selection results 15 Section 5: Extended results: Ancestral Cebinae (H3) positive selection results 16 Section 6: Extended results: Across-capuchins (H3a) positive selection results 17 Section 7: Extended results: Ancestral Cebidae (H4) positive selection results 18 Section 8: Extended results: Squirrel monkeys (Saimiri; H5) positive selection results 19 Figs. S1 to S3 20 Tables S1–S3, S5–S7, S10, and S23 21 References (94 to 172) 22 23 Other Supplementary Materials for this manuscript include the following: 24 Tables S4, S8, S9, S11–S22, and S24–S44 1 25 1) Extended methods & results: Robust capuchin reference genome 26 1.1 Genome assembly: versions and accessions 27 The version of the genome assembly used in this study, Sape_Mango_1.0, was uploaded to a 28 Zenodo repository (see data availability). An assembly (Sape_Mango_1.1) with minor 29 modifications including the removal of two short scaffolds and the addition of the mitochondrial 30 genome assembly was uploaded to NCBI under the accession JAGHVQ. The BioProject and 31 BioSample NCBI accessions for this project and sample (Mango) are PRJNA717806 and 32 SAMN18511585.
    [Show full text]